Chronic kidney disease (CKD) is defined as structural or functional kidney damage or a glomerular filtration rate (GFR) less that 60 mL/min per 1.73 m2 for at least 3 months.1 Approximately 1 of 3 adults with diabetes and 1 of 5 adults with high blood pressure has CKD.2 We estimate that more than 10% of adults in the United States (more than 20 million people) may have CKD. Men with CKD are 50% more likely than women to have kidney failure.2 Due to increased risk for cardiovascular disease, individuals with CKD are 16 to 40 times more likely to die than to reach ESRD.2
The most common risk factors for CKD are diabetes and hypertension.1 Other risk factors associated with progression include those that may be consequent to the underlying
…show more content…
When the GFR remains <15mL/min per 1.73 m2 renal replacement therapy, either dialysis or transplantation is indicated.3 TK is CKD stage 3 with 38 …show more content…
An increased risk of hyperkalemia was associated with this class when combined with ACEI or ARB.5 Thus, aliskiren is not recommended for our patient at this time.
Other antihypertensive drugs have little or no effect on protein excretion. Beta blockers (BB), diuretics, and alpha-1 blockers have a lesser antiproteinuric effect than renin-angiotensin system inhibitors.5 A meta-analysis showed that ACEI lowered protein excretion by 40% compared with 16% for BB, and 14% for other non-calcium channel blocker antihypertensive
Chronic kidney disease (CKD) is a worldwide problem that is currently three times higher for African Americans, Hispanics, Pacific Islanders, American Indians and seniors (The National Kidney Foundation, 2013). CKD occurs when the kidneys are damaged by a pathogen or injury and they can no longer adequately maintain proper levels of regulated chemicals in the bloodstream. There are many risk associated with CKD. According to the National Kidney Foundation, two of the major risks are Chronic Renal Failure (CRF) and Cardiovascular Disease. Currently twenty million American adults have CKD and millions of others are at increased risk. Age has no barrier on getting CKD. People with pre-existing health issues, and a part of certain population
Chronic kidney disease (CKD) is a common disorder and occurs in the elderly population. In younger patients, it
Risk factors play a role to cause congestive heart failure, but if having more than one of the risk factors, it increases one's risk. According to Daniel lee Kulick and Benjamin Wedro, Congestive heart failure is often a consequence of atherosclerotic heart disease and therefore the risk factors are the same. Poorly controlled high blood pressure, high cholesterol, diabetes, smoking, and family history are all contributors to being a risk factor of congestive heart failure. Heart valve disease becomes a risk factor of the patient throughout the years. Other causes of heart failure have their own set of risk factors and preferences and it becomes problem to those diseases.
According to “MedlinePlus,” U.S. National Library of Medicine, "End-stage kidney disease is the last stage of chronic kidney disease. This is when your kidneys can no longer support your body's needs. End-stage kidney disease is also called end-stage renal disease (ESRD)” (“End-stage Kidney Disease”). Renal failure is a disease that prevents the kidneys from getting rid of wastes and extra fluids. It can damage other organs, and it may cause death.
The results also showed that patients in the treatment group had a lower risk of hospitalization for heart failure, progression of albuminuria, and loss of kidney function
Underdiaxonsied and undertreated it is a major concern for the aging population of the United States. One of the first steps is educating the public on early detection techniques and risk factor for developing CKD. High blood pressure and diabetes is a major contributor in developing the disease and thus high risk factor groups should be identified early. This way the individuals can begin implementing lifestyle changes that can not only decrease the rate of kidney function decline but improve it as well. Management of the disease focus on the major complications. Anemia, dyslipidemia, CKD-MBD, nutrition and cardiovascular are the forefront of the disease management. Management with not only medications, but lifestyle changes creates a holistic care plan specialized to each individual patient. By treating not CKD but the individual patient, outcomes will improve. Implementing the health care team as a whole will unify the strengths in modern medicine and thus relieve a huge financial burden that chronic kidney disease yields at a national and local
In the United States, over 5 million patients have heart failure (HF) and approximately 20 million patients have chronic kidney disease (CKD). Both conditions are linked by multiple risk factors including obesity, hypertension, diabetes mellitus, tobacco abuse, and increasing age. The presence of HF increases the risk of CKD and vice versa. Nearly one third of all patients with HF and 70% of Medicare patients with HF have Stage III CKD or greater and approximately 50% of dialysis dependent end stage renal disease (ESRD) patients will develop HF.
Using an existing National VA AKI-CKD study cohort extracted from the VA CDW containing electronic medical records, I will identify those in the cohort diagnosed with AKI using KDIGO along with associated International Classification of Diseases, Ninth Revision (ICD-9) diagnostic codes for AKI or acute renal failure as inclusion criteria in my study population (Kidney Disease Improving Global Outcomes (KDIGO), 2012). I will exclude those who do not fit the set cohort criteria.
Chronic Kidney Disease (CKD) is a disease that is described as a loss of kidney function gradually over time. As kidney function decreases, the waste collection in the body’s blood becomes high and makes the individual feel sick. This disease can lead to other complications in the body such as anemia, poor nutritional health, high blood pressure, and nerve damage. These complications will begin to progress and show as CKD progresses to advanced stages. Early detection of this disease is essential when it comes to treatment. If CKD is diagnosed early enough the disease progression can be slowed down and managed. This disease will eventually lead to failure of the kidneys
A really great website for Mrs. Joaquin to do some research on CKD is www.davita.com. This website explains the disease, treatment option, how to prepare for dialysis, and foods that are healthy for people with CKD. This website is managed and updated by the DaVita’s renal dietitian. Another resource for Mrs. Joaquin to look into would be www.kidney.org. This website is managed by the National Kidney Foundation and is updated frequently. The website explains the disease very well and discusses multiple topics pertaining to CKD. A third website that gives a great explanation of the disease is www.kidneyfund.ord. This website is organized and controlled by the American Kidney Fund. These websites are good resources for Mrs. Joaquin to learn about
In patients with heart failure, hypovolemia, cirrhosis, nephrotic syndrome, or hypoalbuminemia, renal function may be further compromised. BUN, creatinine clearance, and urine output should be monitored closely (Lexi-Comp, 2016).
Chronic kidney disease (CKD) is an irreversible condition that progresses causing kidney dysfunction and then to kidney failure. It is classified by a GFR of <60mL/min for longer than 3 months. There are five stages of CKD: Stage 1 has kidney damage but has a GFR ≥ 90. Stage 2 has mild damage and a GFR of 60-89. Stage 3 has moderate damage and a GFR of 30-59. Stage 4 has severe damage and a GFR of 15-29. Stage 5 is also known as end stage renal disease (ESRD), this is kidney failure with a GFR of ≤ 15 and theses patients are typically on dialysis or in need of an immediate transplant. The leading cause of CKD is diabetes. Hypertension is also a major cause. Since most DM patients have HTN,
Chronic Kidney Disease (CKD) is among the leading causes of mortality throughout the world, and its prevalence and the health care costs resulting from it are considerable and increasing. CKD commonly is silent and asymptomatic until its late stages. Accordingly, CKD is diagnosed prior to symptomatic stage of kidney failure, resulting in delays in proper interventions and the emergence of adverse consequences in the CKD patients
Mr. Armstrong has a history of renal insufficiency and uncontrolled hypertension, along with symptoms of fatigue, pedal edema, and occasional shortness of breath. He does not have a history of trauma or obstruction to his kidneys, but his creatinine and BUN levels are currently at 3.5 mg/dl and 40 mg/dl. Normal creatinine concentration values are 0.7 to 1.2 mg/dl and normal BUN values are 10 to 20 mg/dl; this reveals that Mr. Armstrong’s kidneys are not removing wastes properly (McCance, Huether, Brashers, & Rote, 2014). Mr. Armstrong’s history of renal insufficiency and uncontrolled hypertension is commonly found in patients diagnosed with intrarenal (intrinsic) acute renal failure. Intrarenal acute renal failure can be categorized as
stages, symptoms and risk factors. It also examines the process of kidney transplantation to treat